Dati della Fondazione Gimbe: +13,4% i posti occupati nelle Terapie intensive, +38,4% i decessi
Risultati per: Il significato della carica virale e l’effetto del vaccino anti-COVID-19
Questo è quello che abbiamo trovato per te
Covid, ok dell'Ema ai vaccini per i bambini dai 6 mesi
Via libera ai prodotti Biontech-Pfizer e Moderna per le fasce di età più giovani
High-Flow Nasal Cannula Oxygen Lowers Risk for Intubation and Improves Dyspnea in Patients with COVID-19
Mortality was similar among patients treated with non–rebreather masks or high-flow nasal cannula oxygen.
Covid, Fiaso: Rallenta la curva dei ricoveri, +1,9%
In una settimana aumento lieve. Calo pazienti in intensiva
++ Covid: Fiaso, rallenta la curva dei ricoveri, +1,9% ++
In una settimana aumento lieve. Calo pazienti in intensiva
Covid: Omicron potrebbe avere avuto origine nei topi
Mutazioni su proteina Spike frutto dell’adattamento nei roditori
Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus
New England Journal of Medicine, Volume 387, Issue 16, Page 1528-1529, October 2022.
Audio Interview: Covid-19: Where Are We Heading?
New England Journal of Medicine, Volume 387, Issue 16, October 2022.
Covid: decessi tornano sopra 100, al via quinta dose
Circolare, a 120 giorni da booster o malattia. Prima i fragili
Covid: 58.360 i positivi, 113 vittime. Tasso al 17,7%
Il totale dei casi dall’inizio della pandemia in Italia è di 23.172.370, indica l’aggiornamento del ministero della Salute
Long Covid: nasce centro di ricerca al Gemelli Molise
Obiettivo monitorare gli effetti a lungo termine
Vaccino Covid, 5/a dose a 120 giorni da ultimo booster
La circolare, bivalenti Omicron raccomandati a over 80 e consigliati a over 60
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population
Annals of Internal Medicine, Ahead of Print.
Association of mRNA Vaccination With Clinical and Virological Features of COVID-19
This study uses a prospective cohort of essential and frontline workers in 6 US states with SARS-CoV-2 infection to examine associations between 2 or 3 doses of mRNA COVID-19 vaccine and attenuation of symptoms and viral RNA load across SARS-CoV-2 viral lineages.
Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine
Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose
This study assesses the association between COVID-19 mRNA booster immunization compared with vaccination with the primary mRNA vaccination series alone and odds of hospitalization for COVID-19.